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Abstract  
Serratia peptidase is active proteolytic enzyme which has the potential of cleaving peptide bond.  Present investigation 
deals about the Microbial production of serratia peptidase using Serratia marcescens in small scale fermentor. Batch 
fermentor has been run continuously throughout the night to analyze the production of protein as well as kinetics. Culture 
broth was maintained at 150rpm for 72 hrs. Protein sample was isolated by centrifuging at 3000rpm for 10mints. The result 
revealed that Serratia marcescens showed the enormous production of protein in fed batch fermentor compared to the small 
scale level.  Different substrates were been used for the production of enzyme. Among all cysteine showed the better 
activity as 2 units/ml of enzyme. Enzymatic assay of Serratia peptidase was done at different time interval of crude broth. 
Enzyme activity showed that maximum at 40ºC for 72hrs. It was observed that 0.65 units/ml of enzyme. Fed batch pilot scale 
production of Serratia peptidase was done at 0.5%cystein and 700rpm for 48hrs of run time.  
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INTRODUCTION 
 
     The natural Chelation-Anti-Inflammatory Serratia peptidase 
has had wide clinical use - spanning over twenty-five years 
throughout Europe and Asia - as a viable alternative to salicylates, 
ibuprofen and the more potent NSAIDs. Unlike these drugs, Serratia 
peptidase is a naturally occurring, physiological agent with no 
inhibitory effects on prostaglandins and is devoid of gastrointestinal 
side effects. Uses: 1. Cardiovascular Disease 2. Arthritis 
3.Rheumatoid Arthritis 4.Lung Problems 5.Eye Problems 6.Running 
Nose and sinusitis problems 7.Sports Injuries 8. Inflammation of any 
kind Serratia peptidase is a proteolytic enzyme isolated from the 
micro-organism Serratia marcescens. This enzyme is naturally 
processed commercially today through fermentation and was 
discovered in the silkworm intestine. This immunologically active 
enzyme is completely bound to the alpha 2 macroglobulin in 
biological fluids. Histological studies reveal powerful anti-inflamma-
tory effects of this naturally occurring enzyme. Serratia peptidase 
digests non-living tissue, blood clots, cysts, and arterial plaque and 
inflammation in all forms. 
     NSAIDs are among the most widely prescribed drugs for 
rheumatoid arthritis and other inflammatory joint conditions. Their 
effects are mediated through inhibition of the biosynthesis of 
prostaglandins. They work by irreversibly blocking cyclooxygenase, 
the enzyme which catalyses the reactions of arachidonic acid to 
endoperoxide compounds. The neurological and gastrointestinal side 
effects of these agents have been reviewed in considerable detail. 
All of the NSAIDs, with the exception of Cytotec, inhibit prostaglandin 
El, a local hormone responsible for gastric mucosa cyto protection. A 
common side effect from these medications is gastric ulcers. More 
serious adverse reactions such as blood dyscrasias, kidney damage 
and cardiovascular effects have been noted. Most physicians rotate 
among the ten most widely prescribed NSAIDs, as soon as one 
causes side effects or stops working. 
     The search for a physiologic agent that offers anti-
inflammatory properties without causing side effects may have 
ended with the discovery of the Serratia peptidase (SP) enzyme. SP 
is an anti-inflammatory, proteolytic enzyme isolated from the 
microorganism, SerratiaEl5. This enzyme is naturally present in the 
silkworm intestine and is processed commercially today through 
fermentation. The silkworm has a symbiotic relationship with the 
Serratia microorganisms in its intestines. The enzymes secreted by 
the bacteria in silkworm intestines have a specific affinity to a vital 
tissue and have no detrimental effect on the host’s living cells. By 
dissolving a small hole in the silkworm’s protective cocoon (avital 
tissue), the winged creature is able to emerge and fly away. The 
discovery of this unique biological phenomenon led researchers to 
study clinical applications of the SP enzyme in man. 
 
MATERIALS AND METHODS 
Screening For Serratia peptidase Enzyme Production 
Casein Hydrolysis 
 
     Skimmed milk agar was prepared as follows: Dissolve the 
ingredients, adjust the pH to 7.2, distribute in 200ml portions into 
250ml conical flasks and sterilize by autoclaving at 15lb pressure for 
15minutes. Don’t autoclave skimmed milk powder. Pasteurize the 
skimmed milk at 70oC for 15-20 min. Cool and mix with the 
autoclaved and cooled medium containing peptone and agar. Pour 
the autoclaved and cooled (45-500C) medium into sterile Petri plates 
(20ml each) and allow these to solidify. Label 3 skim milk agar plates 
with name of bacterial organism to be inoculated and the fourth plate 
as control. Make a single line streak inoculation from each culture 
into its labeled Petri plate across the surface of the medium. 
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Incubate the plates (inoculated & uninoculated) for 24-48 hours at 
300C.  
 
Production Media 
 
     Nutrient broth was prepared and inoculates the 1% of serratia 
marcescens mother culture.  Culture broth was maintained in 
150rpm for 24hrs for preparation of preproduction media. 2% of the 
preproduction media are taken for the main production media with 
different substrate concentration.  
 
Composition of Different Production Media: 
Casein as Substrate 
Tryptone   - 3g 
Yeast extract  - 5g 
Glucose   - 5g 
Casein    - 5g 
Glycerol   - 1g 
Distilled water  - 1000ml 
pH        - 7 
 
Cysteine as Substrate 
Tryptone         - 15g 
Yeast extract     - 5g 
L-cysteine      - 0.2g 
NaCl       - 1g 
Disodium phosphate anhydrous- 0.3g 
Sodium bicarbonate   - 2g 
Sodium acetate anhydrous  - 12g 
Sucrose      - 5g 
Distilled water     - 1000ml 
pH        - 7 
 
Enzyme Assay 
 
     Serratia peptidase activity was assayed by the modified 
method of Keay et al[2]. In brief, 0.2 ml of the enzyme was mixed 
thoroughly with 0.5 ml of 0.5% of casein solution. The mixture was 
incubated at 37°C for 10 min. Then the reaction was terminated by 
the addition of 2 ml of 110 mM Trichloroacetic acid and the mixture 
was again incubated for 30 min at 37°C. The incubated solution was 
filtered through Whatman No. 1 filter paper. Then 2 ml from the 
filtrate with 5 ml of 500 mM Na2CO3 and 0.5 ml of Folin’s phenol 
reagent was added and mixed thoroughly. Again the mixture was 
incubated at 37°C for 30 min and the final solution was measured at 
660 nm. One unit of protease activity was defined as the amount of 
enzyme required to liberate 1 µmol of tyrosine in 30 min at 37°C. 
 
Protein Assay 
 
     Protein concentration was measured by the method of Lowry 
et al[6] using bovine serum albumin (Sigma, USA) as the standard. 
In column chromatography elution, the amount of protein was 
measured in terms of the absorbance at 660 nm. The specific activity 
was expressed as the enzyme activity per mg of protein. 
 
Unit Definition 
 
     One unit will hydrolyze casein to produce color equivalent to 
1.0 µmole (181 µg) of tyrosine per minute at pH 7.5 at 37°C (color by 
Folin & Ciocalteu’s reagent). 
 
Final Assay Concentration 
 
     In a 6.00 ml reaction mix, the final concentrations are 42 mM 
potassium phosphate, 0.54% (w/v)casein, 1.7 mM sodium acetate, 
0.8 mM calcium acetate, and 0.1 - 0.2 unit protease. 
 
RESULTS 
 
     In small scale we have got higher results when compare to 
large scale. If we continue further to scale up process, the production 
will be comparatively low. To overcome this we have to do 
alternative methods such as Media Optimization, changing the PH, 
changing various carbon source, nitrogen source & percentage of 
the inoculum. We can also perform immobilization process for 
improving the enzyme efficiency.
 
Table 1. Estimation of Protein By Lowry’s Method 
 
Sample Vol of 
BSA(ml) 
Vol of 
Sample 
(ml) 
Vol of 
Water 
(ml) 
Reagents 
(ml) 
 FC 
(ml) 
 OD Concentra
tion 
( Ug/ml) 
STD 1 0.2  0.8 5  0.5  0.103 20 
STD 2 0.4  0.6 5 10 0.5 30 0.256 40 
STD 3 0.6  0.4 5 min 0.5 min 0.344 60 
STD 4 0.8  0.2 5  0.5  0.423 80 
STD 5 1  0 5  0.5  0.561 100 
T1 2 0.1 0.8 5  0.5  1.269 Un1 
T2 2 0.1 0.8 5  0.5  1.405 Un2 
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Table 2. Estimation of Protein By Lowry’s Method 
 
Sample Vol of BSA 
(ml) 
Vol of 
Sample 
(ml) 
Vol of 
Water 
(ml) 
Reagents 
(ml) 
 FC 
(ml) 
 OD Concentration 
 ( Ug/ml) 
STD 1 0.2  0.8 5  0.5  0.103 20 
STD 2 0.4  0.6 5 10 0.5 30 0.256 40 
STD 3 0.6  0.4 5 Min 0.5 min 0.344 60 
STD 4 0.8  0.2 5  0.5  0.423 80 
STD 5 1  0 5  0.5  0.561 100 
T1 2 0.2 0.8 5  0.5  1.152 Un1 
T2 2 0.2 0.8 5  0.5  1.255 Un2 
Pdn 
media 
2 0.2 0.8 5  0.5 
 
 1.066 Un3 
 
Table 3. Enzyme Activity 
 
Fermentor 
Reading 
Enzyme Activity(µg/ml) Specific Enzyme 
Activity(µg/ml) 
 Filterate 
(mg/ml) 
Non-Filterate 
(mg/ml) 
Filterate 
(mg/ml) 
Non-Filterate 
(mg/ml) 
T1(5.30 pm) 0 0 0 0 
T2(7.30 pm) 0.16 0.14 0.28 0.68 
T3(9.30 pm) 0.32 0.25 0.37 0.91 
T4(11.30 pm) 0.47 0.35 0.43 1.12s 
T5(7.00 am) 0.61 0.44 0.78 1.89 
T6(9.00 am) 0.61 0.44 0.78 1.89 
T7(11.00 am) 0.42 0.38 0.99 2.38 
T8(1.00 pm) 0.34 0.23 1.89 4.54 
 
   
         Fig1. Production Media For Casein                    Fig 2. Casein                 Fig 3. Estimation of Protein By Lowry’s Method Fig 
  
    
           4. Large Scale Level                        Fig 5. Enzymatic Assay                          Fig 6. Growth Curve 
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DISCUSSION 
 
     Present work reveals the Casein as substrate for the 
production of serratia peptidase enzyme. Casein acts as protein 
source which leads to the production of proteolytic enzyme. It has 
clearly confirmed that Serratia marcescens can able to produce 
proteolytic enzyme by casein hydrolysis. Large scale production of 
enzyme is much useful for biomedical application in commercial 
aspects. In present result enzyme activity of both filtrate and non 
filtrate has been taken in different time interval. Fermentor conditions 
were optimized by setting the parameter in different ranges. Growth 
curve of Serratia marcescens in large scale in relatively low 
compared to the small scale level. It has been observed that 0.33 
and 0.65.  It was observed that twice times lower than the normal 
scale production. The result revealed that maximum activity of 
enzyme at temperature of 40ºC for two days. Maximum production 
was observed in the exponential phase of the microorganism during 
the growth. Casein assay shows the filtrate sample has the better 
enzyme activity and has the lower specific enzyme activity. It was 
noticed that maximum activity of 0.61Units/ml enzyme in filtrate 
solution. But in case of non-filtrate has shown better specific enzyme 
activity as 1.89 units/mg of solid. Enzyme activity was checked for 
the commercial available serratia peptidase.  Compared to the 
previous result we had observed the less activity due to the 
environmental factors.  Hereby it needs to optimize the 
concentration of media for large scale level. 
 
CONCLUSION 
 
     Serratia peptidase is one of the important enzyme in 
medicinal field.  It used to cure the different diseases like 
cardiovascular attack and heart diseases. Current study reveals that 
effective production of Serratia peptidase from Serratia marcescens. 
It has been observed the highest activity than previous result in large 
scale level. Characterization of enzyme was done and it was 
effective as 40ºC and pH 7.0.  The activity of enzyme was low in 
large scale level than small scale level of production. Further it needs 
to optimize the substrate to increase the production of enzyme in 
large scale level.  
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